This mini-episode is part of our Inside The Story series, where we highlight some of The Lever’s original reporting and speak with the journalists who wrote the story. Frank Cappello speaks with Julia Rock, who details their new story published by The Lever:Pharmaceutical giants rang in the new year by quietly announcing price hikes in the United States on more than 350 drugs — and they continue to insist these price hikes are necessary for innovation. But new research shows that the business model of America’s largest pharmaceutical companies involves far more spending on enriching shareholders and executives than on research and development.To read the full story, click here.If you enjoyed this story and want to support independent journalism, you can go to LeverNews.com to subscribe to our free newsletter or become a paid supporter.